Health
French Pasteur Institute abandon Covid-19 vaccine development after phase 1 trials fail – FRANCE 24

Issued on: 25/01/2021 – 16:47
Frances Pasteur Institute announced on Monday that it is ending the development of its Covid-19 vaccine after trial results proved disappointing. It appears that the vaccine failed to prove its efficacy in phase 1 trials. The phase 1 of their trial that started in August. Although the vaccine was well tolerated by people, it seems like it didnt spark sufficient immune system response, FRANCE 24s Julia Sieger reports.
Continue Reading
-
Business19 hours ago
Battle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business18 hours ago
5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News15 hours ago
Measles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business15 hours ago
1 ASX dividend stock down 43% I’d buy right now